AWM
TMO icon

Angeles Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Angeles Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.42M Buy
4,914
+37
+0.8% +$20.1K 0.13% 66
2025
Q4 		$2.83M Buy
4,877
+69
+1% +$39K 0.16% 58
2025
Q3 		$2.33M Buy
4,808
+1,187
+33% +$553K 0.14% 56
2025
Q2 		$1.47M Sell
3,621
-241
-6% -$101K 0.1% 71
2025
Q1 		$1.92M Sell
3,862
-81
-2% -$43.9K 0.16% 54
2024
Q4 		$2.05M Buy
3,943
+22
+0.6% +$12.1K 0.17% 53
2024
Q3 		$2.43M Buy
3,921
+19
+0.5% +$11.2K 0.21% 44
2024
Q2 		$2.16M Buy
3,902
+95
+2% +$54.4K 0.2% 44
2024
Q1 		$2.21M Buy
3,807
+26
+0.7% +$14.6K 0.22% 44
2023
Q4 		$2.01M Sell
3,781
-249
-6% -$121K 0.24% 37
2023
Q3 		$2.04M Sell
4,030
-283
-7% -$151K 0.29% 36
2023
Q2 		$2.25M Sell
4,313
-495
-10% -$267K 0.31% 33
2023
Q1 		$2.77M Buy
4,808
+484
+11% +$273K 0.41% 28
2022
Q4 		$2.38M Sell
4,324
-891
-17% -$472K 0.42% 32
2022
Q3 		$2.65M Buy
5,215
+404
+8% +$226K 0.52% 27
2022
Q2 		$2.61M Buy
4,811
+134
+3% +$73.8K 0.52% 29
2022
Q1 		$2.76M Buy
+4,677
New +$2.69M 0.52% 26

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Angeles Wealth Management's TMO Position: Q1 2026 in Review

Angeles Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 0.76% in Q1 2026, buying an estimated $20.1K and bringing the position to 4,914 shares worth $2.42M. The position accounts for 0.13% of the portfolio, ranked #66.

Angeles Wealth Management first reported a position in TMO in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.83M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Angeles Wealth Management held 4,914 shares of Thermo Fisher Scientific worth $2.42M as of Q1 2026.
  • Angeles Wealth Management bought 37 Thermo Fisher Scientific shares in Q1 2026, an estimated $20.1K.
  • Thermo Fisher Scientific made up 0.13% of Angeles Wealth Management's portfolio in Q1 2026, its #66 holding.
  • Angeles Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 17 quarters since.
  • Angeles Wealth Management's Thermo Fisher Scientific position peaked at $2.83M in Q4 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Angeles Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.